Credit: Julie Russell/LLNL
LLNL researchers Nick Fischer and Amy Rasley are characterizing nanolipoprotein particle vaccine formulations using a dynamic light-scattering instrument. Detailed characterization of the nanoparticles provides an important quality control metric for vaccine development. Fischer and Rasley are the co-principal investigators on a project with three other institutions to develop a multi-pathogen vaccine that will protect against three bacterial biothreat pathogens.